CLINICAL complete response (cCR) is a strong predictor of prognosis in patients with unresectable hepatocellular carcinoma ...

The High-Risk Cancer Surveillance Clinic helps patients detect their cancer risk and develop a care plan from there. Sponsored by Overlake Medical Center and Clinics ...

On 12 Feb 2025, Lion TCR announced that its mRNA-encoded T-cell receptor (TCR)-T cell therapy product Liocyx-M004 has received clearance from the U.S. Food and Drug Administration (FDA) to initiate an ...

China: A recent study published in the Annals of Hepatology has emphasized the influence of age on hepatocellular carcinoma ...

Hundreds of a people who have chronic liver disease are being helped by an NHS trust's service that helps them attend vital ...

Investigator Award has been awarded to two surgeon-scientists at the National Cancer Centre Singapore (NCCS) to pursue novel research in liver cancer and head and neck cancers. Globally, liver cancer ...

New model predicts HCC risk in noncirrhotic chronic hepatitis B patients, improving early detection strategies.

To provide best care for women with a personal history of breast cancer, follow-up after treatment completion is necessary. Annual surveillance mammography is an imperative part of this follow-up.

DEAR DR. ROACH: I am a 66-year-old white male who is active and relatively healthy. I have recently been diagnosed with prostate cancer. One blood test showed a PSA level of 13 ng/mL, and a second was ...

Disparities in liver cancer risk and outcomes in the LGBTQ community: A literature review. Non-contrast MRI as a surveillance tool for recurrent hepatocellular carcinoma after curative treatment: A ...

Mortality trends and racial disparities in hepatocellular carcinoma associated with metabolic syndrome in the United States and Texas: A 21-year analysis (1999-2020) using CDC WONDER database. This is ...